0001958244-24-005801.txt : 20241202 0001958244-24-005801.hdr.sgml : 20241202 20241202170723 ACCESSION NUMBER: 0001958244-24-005801 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20241202 DATE AS OF CHANGE: 20241202 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001556263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 453772460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37813 FILM NUMBER: 241520016 BUSINESS ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-744-1340 MAIL ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: LS22, Inc. DATE OF NAME CHANGE: 20120815 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Simonian Nancy A CENTRAL INDEX KEY: 0001359574 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O SYROS PHARMACEUTICALS, INC. STREET 2: 620 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 144 1 primary_doc.xml 144 0001359574 XXXXXXXX LIVE 0001556263 SYROS PHARMACEUTICALS, INC. 001-37813 35 Cambridge Park Drive 4th Floor Cambridge MA 02140 1-617-744-1340 Nancy Cole Director SYROS PHARMACEUTICALS, INC. Goldman Sachs & Co. LLC 200 West Street New York NY 10282 37070 10016.31 26832457 12/02/2024 NASDAQ SYROS PHARMACEUTICALS, INC. 08/24/2016 Acquired as compensation -- Restricted Stock Units The Issuer N 30404 08/24/2016 Compensation SYROS PHARMACEUTICALS, INC. 10/17/2016 Acquired as compensation -- Restricted Stock Units The Issuer N 6666 10/17/2016 Compensation Y 12/02/2024 Goldman Sachs & Co. LLC on behalf of Nancy Cole